Refine
Year of publication
Document Type
- Article (733)
- Preprint (686)
- Conference Proceeding (6)
- Working Paper (5)
- Report (3)
- Doctoral Thesis (1)
Has Fulltext
- yes (1434)
Is part of the Bibliography
- no (1434)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- immunotherapy (6)
- COVID-19 (5)
- ALICE experiment (4)
- Breast cancer (4)
- Collective Flow (4)
- Diagnostic markers (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- cancer (4)
- child (4)
- children (4)
- lung cancer (4)
- ALICE (3)
- Bipolar disorder (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- Psychiatric disorders (3)
- biomarker (3)
- hematopoietic stem cell transplantation (3)
- pp collisions (3)
- radical prostatectomy (3)
- 140Ce (2)
- ADHD (2)
- Aspergillus fumigatus (2)
- Atrial fibrillation (2)
- Beauty production (2)
- COVID-19 surveillance (2)
- Cancer (2)
- Charm physics (2)
- Depression (2)
- Diagnostik (2)
- Drug therapy (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Früherkennung (2)
- Genetics (2)
- Heart failure (2)
- Heavy Quark Production (2)
- Hypertension (2)
- Immunology (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Mammakarzinom (2)
- NIRS (2)
- Nachsorge (2)
- Nuclear reactions (2)
- Omicron (2)
- Oncology (2)
- Outcome (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- QCD (2)
- Rehabilitation (2)
- Richtlinie (2)
- SARS-CoV-2 monitoring (2)
- Shell model (2)
- Single electrons (2)
- Structural plasticity (2)
- Suicide (2)
- Superficial vein thrombosis (2)
- Surgery (2)
- Treatment (2)
- Ursus arctos (2)
- bipolar disorder (2)
- breast cancer (2)
- data science (2)
- diagnosis (2)
- follow‑up (2)
- functional outcome (2)
- guideline (2)
- inflammation (2)
- invasive fungal disease (2)
- leukemia (2)
- outcome (2)
- prostate cancer (2)
- psoriasis (2)
- screening (2)
- 16 segment AHA model (1)
- 19F (1)
- 900 GeV (1)
- ACL (1)
- AIS (1)
- AKI (1)
- AKT (1)
- ALICE detector (1)
- ARDS (1)
- Actin (1)
- Active middle ear implants (1)
- Acute coronary syndrome (1)
- Acute inflammation (1)
- Adjustment of dosage at steady state (1)
- Adult neurogenesis (1)
- Adverse events (1)
- Age groups (1)
- Amino acid analysis (1)
- Anlegerschutz (1)
- Annual General Meeting (1)
- Annual general meeting (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Antibody isotypes (1)
- Antifungal agents (1)
- Antigen-presenting cells (1)
- Antirheumatic agents (1)
- Aortic valve (1)
- Aortic valve replacement (1)
- Apes (1)
- Artesunate (1)
- Artificial Intelligence (1)
- Artificial intelligence (1)
- Aspergillosis (1)
- Aspergillus (1)
- Atomic and Molecular Physics (1)
- Auditory system (1)
- Autorschaft (1)
- Awareness campaign (1)
- B cell receptor (1)
- B.1.1.529 (1)
- BA.4 (1)
- BA.5 (1)
- BFIS (1)
- BI1361849 (1)
- Bacteria (1)
- Bankberatung (1)
- Behavior (1)
- Biliary tree (1)
- Biodiversity (1)
- Biodiversity Data (1)
- Biological (1)
- Biological heart valves (1)
- Biomarker (1)
- Biomarkers (1)
- Biomonitoring (1)
- Bioprosthesis (1)
- Blood pressure (1)
- Body mass index (1)
- Bone conduction devices (1)
- Bone metastases (1)
- Bone metastasis (1)
- Bone strength assessment (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Brain DNA methylation (1)
- Brain injury (1)
- Breast neoplasms (1)
- Breast tumors (1)
- Business strategy in drug development (1)
- CD3/19 depletion (1)
- CD34 selection (1)
- CD36 (1)
- CEO Speeches (1)
- CEO speeches (1)
- CHRNA10 (1)
- CHRNA7 (1)
- CHRNA9 (1)
- CIK cells (1)
- COMT (1)
- COVID 19 (1)
- CRPC (1)
- CT pulmonary angiography (1)
- CT radiation exposure (1)
- CTLA-4 (1)
- CV9202 (1)
- CVID (1)
- CWS Studiengruppe (1)
- Calcium (1)
- Cancer check up (1)
- Cancer detection (1)
- Cancer detection and diagnosis (1)
- Candida spp (1)
- Cardiac implantable electronic devices (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy (1)
- Cardiac surgery (1)
- Cardiac troponin (1)
- Cardiovascular biology (1)
- Cardiovascular disease risk (1)
- Cardiovascular diseases (1)
- Cardiovascular magnetic resonance (1)
- Catheter ablation (1)
- Cell binding (1)
- Cell membranes (1)
- Cell staining (1)
- Cellular imaging (1)
- Centrality Class (1)
- Centrality Selection (1)
- Cherenkov counter: lead-glass (1)
- Child (1)
- Child abuse (1)
- Children (1)
- Chronic obstructive pulmonary disease (1)
- Circadian (1)
- Clinical Trials and Observations (1)
- Clinical genetics (1)
- Clinical study (1)
- Clinical trial (1)
- Clinical variation (1)
- Closure (1)
- Cohort studies (1)
- Coincidence measurement (1)
- Collective Flow, (1)
- Combo® DTS (1)
- Community ecology (1)
- Comparative effectiveness research (1)
- Comparison with QCD (1)
- Complexity (1)
- Computational models (1)
- Computational science (1)
- Computed tomography pulmonary angiography (CTPA) (1)
- Computer-aided drug design (1)
- Congenital anomalies (1)
- Consensus (1)
- Consensus document (1)
- Consensus statement (1)
- Conservation (1)
- Conservation biology (1)
- Critical care (1)
- Cryoballoon (1)
- Cryoelectron microscopy (1)
- Cryoelectron tomography (1)
- DNA sequence analysis (1)
- DNA-PAINT (1)
- DYT1 (1)
- Death rates (1)
- Dendritic spines (1)
- Denosumab (1)
- Dermatomyositis (1)
- Detection workflow (1)
- Developmental programming (1)
- Diagnosis (1)
- Digital breast tomosynthesis (DBT) (1)
- Digital mammography (1)
- Digitization (1)
- Dilated cardiomyopathy (1)
- Diphosphonates (1)
- Direct reactions (1)
- Dopamine (1)
- Drug screens (1)
- Dynamical systems (1)
- Early (prenatal and postnatal) life experiences (1)
- Ecological networks (1)
- Ecology (1)
- Ecosystem ecology (1)
- Ejection fraction (1)
- Elderly (1)
- Electromagnetic transitions (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Embryos (1)
- Employment (1)
- Ena/VASP proteins (1)
- Endothelium (1)
- Entorhinal cortex lesion (1)
- Environmental enrichment (1)
- Environmental impact (1)
- Enzyme-linked immunoassays (1)
- Epilepsy (1)
- Europe (1)
- European Society for Immunodeficiencies (ESID) (1)
- Everolimus (1)
- Excitability (1)
- Exercise training (1)
- Exosomes (1)
- Experimental Finance (1)
- Extended donor criteria (1)
- FBS (1)
- FFLU (1)
- FGFR (1)
- Falciparum (1)
- Femoral neck (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Financial Advice (1)
- Finanzbildung (1)
- Fistula (1)
- Flow cytometry (1)
- Follow-up (1)
- Fondaparinux (1)
- Forschung (1)
- Fracture risk (1)
- Frailty (1)
- Functional outcome (1)
- Functional outcomes (1)
- FungiScope® registry (1)
- GPS collar (1)
- Gene expression (1)
- General practitioners (1)
- Genetic causes of cancer (1)
- Genetic testing (1)
- German PID-NET registry (1)
- Global positioning system (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- Guidelines (1)
- HADES (1)
- HBT (1)
- HER2-positive (1)
- HNO (1)
- HPV-positive OPSCC (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hard Scattering (1)
- Health policy (1)
- Heart (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Hematologic malignancies (1)
- Hematology (1)
- Hepatocellular carcinoma (1)
- Herafill (1)
- Herbaria (1)
- High-energy neutron detection (1)
- Histology (1)
- Household Finance (1)
- Human behaviour (1)
- Human genetics (1)
- Hypofractionated radiotherapy (1)
- ICU (1)
- IFN-β (1)
- ISS (1)
- IgG substitution therapy (1)
- Immune response (1)
- Immunity (1)
- Immunoassays (1)
- Immunogenetics (1)
- Immunology and Microbiology Section (1)
- Immunomonitoring (1)
- Implantable cardioverter-defibrillator (1)
- Inclusive spectra (1)
- Inflammation (1)
- Intensity interferometry (1)
- Interleukin-17A (1)
- Intra-abdominal infection (1)
- Invariant Mass Distribution (1)
- Invasive candidiasis (1)
- Invasive fungal infections (1)
- Inverse kinematics (1)
- Ionisation energy loss (1)
- Isoproterenol (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jurkat (1)
- K48-linked (1)
- K63-linked (1)
- KDIGO (1)
- KOOS IV (1)
- Kidney (1)
- Knochendefektheilung (1)
- Kupffer cells (1)
- Köcherfliegen (1)
- LASS (1)
- LFP (1)
- Laparostomy (1)
- Lee-type (1)
- Lehre (1)
- Leukemias (1)
- Library screening (1)
- Lipid signaling (1)
- Literarischer Stil (1)
- Literaturwissenschaft (1)
- Lomentospora prolificans (1)
- Low-molecular-weight heparin (1)
- Luciferase (1)
- Lumbar spine (1)
- Lymphoid Neoplasia (1)
- MACS (1)
- Machine learning (1)
- Macrophages (1)
- Malaria (1)
- Malignancy (1)
- Market Efficiency (1)
- Market efficiency (1)
- Masquelet (1)
- Masquelet technique (1)
- Material budget (1)
- Maternal separation (1)
- Mena/VASP (1)
- Mental health and psychiatry (1)
- Mesh (1)
- Metagenomics (1)
- MicroRNAs (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Mittelhessen (1)
- Mixed hearing loss (1)
- Models & methods for nuclear reactions (1)
- Molecular neuroscience (1)
- Monitoring (1)
- Monte Carlo (1)
- Motor control (1)
- Mouse models (1)
- Multi-Parton Interactions (1)
- Multi-neutron detection (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multimodal imaging (1)
- Multiparametric MRI (1)
- Multiple sclerosis (1)
- Multivariate analysis (1)
- Mutation databases (1)
- Mycoses (1)
- Myocardial infarction (1)
- Myocardial perfusion (1)
- Myocardial segmentation (1)
- NADPH oxidase (1)
- NMR spectroscopy (1)
- NSG mice (1)
- NVBP (1)
- Neoadjuvant therapy (1)
- Neural network (1)
- Neuroinflammation (1)
- Neuroscience (1)
- Neutron physics (1)
- Neutropenia (1)
- Non-small cell lung cancer (1)
- Non-trauma (1)
- Nordhessen (1)
- Nox1 (1)
- NoxO1 (1)
- Nuclear modification factor (1)
- Nuclear resonance fluorescence (1)
- Nuclear structure & decays (1)
- Nucleon induced nuclear reactions (1)
- Nutrition (1)
- ORL (1)
- Observational (1)
- Oldest-old (1)
- Open abdomen (1)
- Organ allocation (1)
- Osteoporosis diagnosis (1)
- Otorhinolaryngology (1)
- Outcome assessment (1)
- Outpatients (1)
- Ovarian cancer (1)
- P2X7 receptor (1)
- PD-1 (1)
- PD-L1 (1)
- PID prevalence (1)
- PKD (1)
- PKD/IC (1)
- PRRT2 (1)
- PSA screening (1)
- PSA-Screening (1)
- PYTHIA (1)
- Pacemaker (1)
- Paediatric research (1)
- Pancreas transplantation (1)
- Pancreatitis (1)
- Pandemic (1)
- Particle and Resonance Production (1)
- Pathological complete response (1)
- Pb–Pb (1)
- Pediatric infections (1)
- Pediatric patients (1)
- Pediatrics (1)
- Peritoneal macrophages (1)
- Peritonitis (1)
- Personalized medicine (1)
- Phosphorylation (1)
- Physical activity (1)
- Plasmodium (1)
- Plastic scintillator array (1)
- Pneumonia (1)
- Population-based screening (1)
- Post treatment (1)
- Post-traumatic stress disorder (1)
- Predictive markers (1)
- Prevention (1)
- Preventive medicine (1)
- Production Cross Section (1)
- Prognosis (1)
- Prognostic models (1)
- Properties of Hadrons (1)
- Prostata-specific antigen (1)
- Prostataspezifisches Antigen (1)
- Prostate cancer (1)
- Proteinkinase (1)
- Proton–proton (1)
- Prävention (1)
- Pseudo HE-images (1)
- Psychiatry (1)
- Psychological and psychosocial issues (1)
- Pygmy Dipole Resonance (1)
- Quality of life (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- Quasi-free scattering (1)
- Quasi-particle phonon model (1)
- Quinine (1)
- REMS (1)
- RNA (1)
- RTS (1)
- Radiative capture (1)
- Radical prostatectomy (1)
- Radiofrequency (1)
- Radiomics (1)
- Raman spectroscopy (1)
- Rapidity Range (1)
- Re-exploration (1)
- Re-injury (1)
- Reactions with relativistic radioactive beams (1)
- Reactive oxygen species (1)
- Recall rate (1)
- Recurrence (1)
- Registries (1)
- Rehospitalization (1)
- Reintervention (1)
- Rejection (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Renal replacement therapy (1)
- Research (1)
- Research Infrastructure (1)
- Residency (1)
- Resolution Parameter (1)
- Resonance reactions (1)
- Return to play (1)
- Return to sports (1)
- Rhabdomyoma (1)
- Rhabdomyosarcoma (1)
- Risk assessment (1)
- Ryanodine (1)
- SARS CoV 2 (1)
- SARS-CoV-2 (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SMAD (1)
- Saarland (1)
- Scedosporium spp. (1)
- Seasonal variation (1)
- Secondary prevention (1)
- Seizure (1)
- Semantics (1)
- Sensory systems (1)
- Serine proteases (1)
- Severe malaria (1)
- Single muons (1)
- Small molecules (1)
- Solar insolation (1)
- South West Germany (1)
- Specialist training (1)
- Spectrin (1)
- Spectroscopic factors (1)
- Spectroscopic factors & electromagnetic moments (1)
- Stress vulnerability/resilience genes (1)
- Sub-segmentation (1)
- Sunlight (1)
- Superoxide (1)
- Survival analysis (1)
- Sustainable Finance (1)
- Synaptic plasticity (1)
- Synaptopodin (1)
- Synthetic (1)
- Systematic Uncertainty (1)
- T-cell (1)
- TAVI (1)
- TGF-beta (1)
- TGFB-induced factor homeobox 1 (1)
- TGFβ (1)
- TGIF (1)
- TOR1A (1)
- TR (1)
- Taxonomy (1)
- Tea (1)
- Teaching (1)
- Technical data (1)
- Technique (1)
- Textual Analysis (1)
- Textual Sentiment (1)
- Textual analysis (1)
- Textual sentiment (1)
- Therapeutics (1)
- Therapy (1)
- Thoracic trauma (1)
- Time Projection Chamber (1)
- Timing (1)
- Tracking (1)
- Transcriptome analysis (1)
- Transition radiation detector (1)
- Translation (1)
- Transverse momentum (1)
- Trauma (1)
- Trigger (1)
- Triple negative (1)
- Two-hit hypothesis (1)
- Ultrasound (1)
- University hospitals (1)
- Universitätskliniken (1)
- Urinary continence (1)
- Urinary incontinence (1)
- VASP (1)
- VEGF receptor 2 internalization and signaling (1)
- Variant of concern (1)
- Vascular emergencies (1)
- Vector Boson Production (1)
- Venous thrombosis (1)
- Vesicles (1)
- Voriconazole (1)
- Vorsorgeuntersuchung (1)
- Wastewater-based epidemiology (WBE) (1)
- Weiterbildung (1)
- X-ray crystallography (1)
- Xenon-based gas mixture (1)
- Z-inspection (1)
- accessory proteins (1)
- activity sensors (1)
- acute lymphoblastic leukemia (1)
- adenocarcinoma (1)
- alcoholic hepatitis (1)
- allogeneic stem cell transplant (1)
- allogeneic stem cell transplantation (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- animal personality (1)
- anti-EGFR therapy (1)
- antibiotic resistance (1)
- antibodies (1)
- antifungal combination therapy (1)
- antifungal therapy (1)
- aortic stenosis (1)
- apex (1)
- arachidonate 12/15-lipoxygenase (Alox12/15) (1)
- artifacts (1)
- artificial intelligence (1)
- astrocytes (1)
- atherosclerosis (1)
- attention deficit hyperactivity disorder (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- autoantibodies (1)
- b-cell lymphomas (1)
- bacteremia (1)
- behavioural syndrome (1)
- bendamustine (1)
- bioactivity testing (1)
- biodiversity (1)
- biogeographic legaciese (1)
- bloodstream infections (1)
- bone marrow derived mononuclear cells (1)
- bone marrow mononuclear cells (1)
- brain injury (1)
- brown bear (1)
- cAMP (1)
- cGMP (1)
- calcium-independent phospholipase A2β (1)
- calorimeter: electromagnetic (1)
- calretinin (1)
- candidemia (1)
- capture (1)
- cardiac magnetic resonance (1)
- castration resistance (1)
- cell lines (1)
- cell stress (1)
- cell-free protein synthesis (1)
- central nervous system (1)
- ceramide synthase (1)
- ceramides (1)
- cerium (1)
- chemorefractory metastatic colorectal cancer (1)
- chemotherapy (1)
- chemotherapy regimen (1)
- chimeric antigen receptor (CAR) (1)
- chimeric antigen receptor t-cell therapy (1)
- chimeric antigen receptors (1)
- cholestasis (1)
- chronic kidney disease (1)
- chronic total occlusion (1)
- cisplatin (1)
- clinical research (1)
- cohort study (1)
- colon (1)
- combined modality therapy (1)
- component study (1)
- coronary disease (1)
- critical size defect (1)
- cross-section (1)
- cytokine (1)
- dE/dx (1)
- damage detection (1)
- data quality (1)
- decision aids (1)
- delirium (1)
- dementia (1)
- dentate gyrus (1)
- depression (1)
- detector (1)
- diagnostics (1)
- disease prevalence (1)
- disease progression (1)
- double hierarchical model (1)
- double immune checkpoint inhibition (1)
- early recognition (1)
- easyPACId (1)
- ecological and phytosociological classification (1)
- ectosomes (1)
- electroencephalography (EEG) (1)
- electronics: readout (1)
- endocannabinoids (1)
- endothelial cells (1)
- entorhinal cortex lesion (1)
- ethical co-design (1)
- ethics (1)
- excitation transport (1)
- exosomes (1)
- experimental results (1)
- extracellular vesicles (1)
- facial nerve functional outcome (1)
- familial infantile epilepsy (1)
- fatigue testing (1)
- fibre: optical (1)
- fibrosis (1)
- flow cytometry (1)
- fluorine (1)
- fondaparinux (1)
- forest classification (1)
- forest functional similarity (1)
- fragment-based screening (1)
- galactomannan (1)
- gene expression (1)
- genetic phenotypes (1)
- geriatric medicine (1)
- glass fiber reinforced materials (1)
- guidelines (1)
- head and neck neoplasms (1)
- head-and-neck cancer (1)
- healthcare (1)
- hearing nerve (1)
- heavy ion experiments (1)
- hematopoietic cell transplantation (1)
- hemiplegic migraine (1)
- homeostatic synaptic scaling (1)
- human natural killer cell (1)
- human subjects (1)
- hypertension and anti-hypertensive treatment (1)
- imaging (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitor (ICI) (1)
- immune monitoring (1)
- immune reconstitution (1)
- immunohistochemistry (1)
- impulsivity (1)
- incontinence (1)
- induced membrane (1)
- induction therapy (1)
- infants (1)
- infection (1)
- infections (1)
- inflammasome (1)
- intensive care admission and mortality (1)
- interferon regulatory factor 9 (IRF9) (1)
- interleukin-1β (1)
- interoperability (1)
- intratumoral (1)
- intrinsically disordered region (1)
- invasive mold infection (1)
- layer-specificity (1)
- learning loss (1)
- leukapheresis (1)
- light harvesting networks (1)
- light–energy conversion (1)
- lipids (1)
- lipiodol (1)
- lipoxin A4 (1)
- liver metastasis (1)
- low molecular weight heparin (1)
- low-dose imaging (1)
- lymphoma (1)
- mRNA active cancer immunotherapy (1)
- mTOR (1)
- mTOR inhibitor (1)
- machine learning (1)
- magnetic resonance imaging of the brain (1)
- major depression (1)
- malignant melanoma (1)
- mast cells (1)
- mechanical accuracy (1)
- membranous urethra (1)
- mesenchymal stromal cells (1)
- metabolic syndrome (1)
- metastasis (1)
- metastatic prostate cancer (1)
- microparticles (1)
- microsurgical treatment (1)
- microvesicles (1)
- microwave ablation (1)
- mid-term urinary continence (1)
- mindfulness (1)
- minimal information requirements (1)
- misallocation rate (1)
- misinterpretation rate (1)
- mitral regurgitation (1)
- mitral valve surgery (1)
- mortality (1)
- movement (1)
- multicenter study (1)
- multiparametric magnetic resonance imaging (1)
- multivariate mixed model (1)
- myocardial fibrosis (1)
- n_TOF (1)
- natural products (1)
- neonates (1)
- nerve-sparing surgery (1)
- neurofeedback (1)
- neutron (1)
- neutropenia (1)
- non-ST-segment elevation acute coronary syndrome (1)
- non-neutropenic episode (1)
- nonstructural proteins (1)
- nucleosynthesis (1)
- obesity (1)
- olfaction (1)
- open quantum systems (1)
- optical coherence tomography (1)
- organ preservation (1)
- organotypic slice cultures (1)
- overlooking rate (1)
- p47phox (1)
- pad-test (1)
- patients (1)
- pediatric patients (1)
- penile cancer (1)
- perforant path transection (1)
- perforin (1)
- personality (1)
- phagocytosis (1)
- phantom study (1)
- phenotypic spectrum (1)
- phylogenetic community distance (1)
- pneumonia (1)
- polygenic risk score (1)
- polymerase chain reaction (1)
- polyubiquitin (1)
- preclinical (1)
- primary biliary cholangitis (1)
- primary biliary cirrhosis (1)
- primary immunodeficiency (PID) (1)
- primary sclerosing cholangitis (1)
- proteins (1)
- proteobacteria (1)
- proteomics (1)
- psychotherapy process (1)
- quantum transport (1)
- quark gluon plasma (1)
- radar-based structural health monitoring (1)
- randomized controlled trial (RCT) (1)
- re-exposure (1)
- rechallenge (1)
- registry for primary immunodeficiency (1)
- reintroduction (1)
- repeatability (1)
- reproducibility (1)
- residual intra‐individual variability (1)
- resolution (1)
- resolution of inflammation (1)
- rhabdomyosarcoma (1)
- rigor (1)
- risk assessment (1)
- rituximab (1)
- robot-guided stereotaxy (1)
- s-process (1)
- sarcoma (1)
- scaffold size (1)
- scar (1)
- schizophrenia (1)
- school closure (1)
- second line therapy (1)
- secukinumab (1)
- semiconductors (1)
- simplified production (1)
- single subject classification (1)
- sleep disordered breathing (1)
- smart home (1)
- smart living (1)
- solid tumor (1)
- specialized pro-resolving lipid mediators (SPMs) (1)
- species differences (1)
- spectra (1)
- sprouting angiogenesis (1)
- stability (1)
- standardization (1)
- stereotactic frame (1)
- stereotactic neurosurgery (1)
- stroke (1)
- structural proteins (1)
- student achievement (1)
- survival (1)
- systematic review (1)
- tandem mass spectrometry (1)
- targeted therapy (1)
- telmisartan (1)
- temporal classification (1)
- therapeutic alliance (1)
- tip cell filopodia formation (1)
- toll-like receptor (1)
- tomography (1)
- treatment (1)
- treatment resistance (1)
- treatment response (1)
- tropical forests (1)
- trustworthy AI (1)
- trustworthy AI Co-design (1)
- tumor (1)
- tumor microenvironment (1)
- tumor microenvironment (TME) (1)
- type I interferons (IFNs) (1)
- tyrosine kinase inhibitor (TKI) (1)
- ubiquitin-conjugating enzymes (1)
- urinary incontinence (1)
- ursodeoxycholic acid (1)
- uveal melanoma (1)
- variant of concern (1)
- vascular calcification (1)
- vascular dysfunction and inflammation (1)
- vegetation monitoring (1)
- venous thrombosis (1)
- versican (VCAN) (1)
- vestibular schwannoma (1)
- viral tracing (1)
- virtual reality (1)
- wastewater-based epidemiology (WBE) (1)
- web of things (1)
- weed communities (1)
- wind turbine blades (1)
- Öffentlichkeit (1)
- ß-D-glucan (1)
- γ-ray spectroscopy (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1128)
- Frankfurt Institute for Advanced Studies (FIAS) (961)
- Informatik (928)
- Medizin (189)
- Geowissenschaften (48)
- Biowissenschaften (9)
- ELEMENTS (8)
- Biochemie, Chemie und Pharmazie (7)
- Georg-Speyer-Haus (6)
- Institut für Ökologie, Evolution und Diversität (6)
The first measurement of the cross section for coherent J/ψ photoproduction as a function of |t|, the square of the momentum transferred between the incoming and outgoing target nucleus, is presented. The data were measured with the ALICE detector in ultra-peripheral Pb–Pb collisions at a centre-of-mass energy per nucleon pair √sNN = 5.02 TeV with the J/ψ produced in the central rapidity region |y| < 0.8,
which corresponds to the small Bjorken-x range (0.3 − 1.4) × 10−3.
The measured |t|-dependence is not described by computations based only on the Pb nuclear form factor, while the photonuclear cross section is better reproduced by models including shadowing according to the leading-twist approximation, or gluon-saturation effects from the impact-parameter dependent Balitsky–Kovchegov equation. These new results are therefore a valid tool to constrain the relevant model parameters and to investigate the transverse gluonic structure at very low Bjorken-x.
The first measurement of the coherent photoproduction of ρ0 vector mesons in ultra-peripheral Xe–Xe collisions at √sNN = 5.44 TeV is presented. This result, together with previous HERA γ p data and γ –Pb measurements from ALICE, describes the atomic number (A) dependence of this process, which is particularly sensitive to nuclear shadowing effects and to the approach to the black-disc limit of QCD at a semi-hard scale. The cross section of the Xe + Xe → ρ0 + Xe + Xe process, measured at midrapidity through the decay channel ρ0 → π+π−, is found to be dσ/dy = 131.5 ± 5.6(stat.)+17.5 −16.9(syst.) mb. The ratio of the continuum to resonant contributions for the production of pion pairs is also measured. In addition, the fraction of events accompanied by electromagnetic dissociation of either one or both colliding nuclei is reported. The dependence on A of cross section for the coherent ρ0 photoproduction at a centre-of-mass energy per nucleon of the γ A system of Wγ A,n = 65 GeV is found to be consistent with a power-law behaviour σ(γ A → ρ0 A) ∝ Aα with a slope α = 0.96 ± 0.02(syst.). This slope signals important shadowing effects, but it is still far from the behaviour expected in the black-disc limit.
ϒ production and nuclear modification at forward rapidity in Pb–Pb collisions at √sNN = 5.02TeV
(2021)
The production of ϒ mesons in Pb–Pb collisions at a centre-of-mass energy per nucleon pair √sNN = 5.02 TeV is measured with the muon spectrometer of the ALICE detector at the LHC. The yields as well as the nuclear modification factors are determined in the forward rapidity region 2.5 < y < 4.0, as a function of rapidity, transverse momentum and collision centrality. The results show that the production of the ϒ(1S) meson is suppressed by a factor of about three with respect to the production in proton–proton collisions. For the first time, a significant signal for the ϒ(2S) meson is observed at forward rapidity, indicating a suppression stronger by about a factor 2–3 with respect to the ground state. The measurements are compared with transport, hydrodynamic, comover and statistical hadronisation model calculations.
Annihilation dynamics plays a fundamental role in the baryon–antibaryon interaction (B–B) at lowenergy and its strength and range are crucial in the assessment of possible baryonic bound states. Experimental data on annihilation cross sections are available for the p–p system but not in the low relative momentum region. Data regarding the B–B interaction with strange degrees of freedom are extremely scarce, hence the modeling of the annihilation contributions is mainly based on nucleon–antinucleon (N–N) results, when available. In this letter we present a measurement of the p–p, p–⊕p– and – interaction using correlation functions in the relative momentum space in high-multiplicity triggered pp collisions at √s = 13 TeV recorded by ALICE at the LHC. In the p–p system the couplings to the mesonic channels in different partial waves are extracted by adopting a coupled-channel approach with recent χEFT potentials. The inclusion of these inelastic channels provides good agreement with the data, showing a significant presence of the annihilation term down to zero momentum. Predictions obtained using the Lednický–Lyuboshits formula and scattering parameters obtained from heavy-ion collisions, hence mainly sensitive to elastic processes, are compared with the experimental p–⊕p– and – correlations. The model describes the – data and underestimates the p–⊕p– data in the region of momenta below 200 MeV/c. The observed deviation indicates a different contribution of annihilation channels to the two systems containing strange hadrons.
Z-boson production in p-Pb collisions at √sNN = 8.16 TeV and Pb-Pb collisions at √sNN = 5.02 TeV
(2020)
Measurement of Z-boson production in p-Pb collisions at sNN−−−√ = 8.16 TeV and Pb-Pb collisions at sNN−−−√ = 5.02 TeV is reported. It is performed in the dimuon decay channel, through the detection of muons with pseudorapidity −4 < ημ < −2.5 and transverse momentum pμT > 20 GeV/c in the laboratory frame. The invariant yield and nuclear modification factor are measured for opposite-sign dimuons with invariant mass 60 < mμμ < 120 GeV/c2 and rapidity 2.5 < yμμcms < 4. They are presented as a function of rapidity and, for the Pb-Pb collisions, of centrality as well. The results are compared with theoretical calculations, both with and without nuclear modifications to the Parton Distribution Functions (PDFs). In p-Pb collisions the center-of-mass frame is boosted with respect to the laboratory frame, and the measurements cover the backward (−4.46 < yμμcms < −2.96) and forward (2.03 < yμμcms < 3.53) rapidity regions. For the p-Pb collisions, the results are consistent within experimental and theoretical uncertainties with calculations that include both free-nucleon and nuclear-modified PDFs. For the Pb-Pb collisions, a 3.4σ deviation is seen in the integrated yield between the data and calculations based on the free-nucleon PDFs, while good agreement is found once nuclear modifications are considered.
The first results on K∗(892)± resonance production in inelastic pp collisions at LHC energies of √s = 5.02, 8, and 13 TeV are presented. The K∗(892)± has been reconstructed via its hadronic decay channel K∗(892)± → K0 S + π± with the ALICE detector. Measurements of transverse momentum distributions, pT-integrated yields, and mean transverse momenta for charged K∗(892) are found to be consistent with previous ALICE measurements for neutral K∗(892) within uncertainties. For pT > 1 GeV/c the K∗(892)± transverse momentum spectra become harder with increasing centre-of-mass energy from 5.02 to 13 TeV, similar to what previously observed for charged kaons and pions. For pT < 1 GeV/c the K∗(892)± yield does not evolve significantly and the abundance of K∗(892)± relative to K is rather independent of the collision energy. The transverse momentum spectra, measured for K∗(892)± at midrapidity in the interval 0 < pT < 15 GeV/c, are not well described by predictions of different versions of PYTHIA 6, PYTHIA 8 and EPOS-LHC event generators. These generators reproduce the measured pTintegrated K∗±/K ratios and describe well the momentum dependence for pT < 2 GeV/c.
Measurements of the production of muons from heavy-flavour hadron decays in Pb–Pb collisions at √sNN = 5.02 and 2.76 TeV using the ALICE detector at the LHC are reported. The nuclear modification factor RAA at √sNN = 5.02 TeV is measured at forward rapidity (2.5 < y < 4) as a function of transverse momentum pT in central, semi-central, and peripheral collisions over a wide pT interval, 3 < pT < 20 GeV/c, in which muons from beauty-hadron decays are expected to take over from charm as the dominant source at high pT (pT > 7 GeV/c). The RAA shows an increase of the suppression of the yields of muons from heavy-flavour hadron decays with increasing centrality. A suppression by a factor of about three is observed in the 10% most central collisions. The RAA at √sNN = 5.02 TeV is similar to that at √sNN = 2.76 TeV. The precise RAA measurements have the potential to distinguish between model predictions implementing different mechanisms of parton energy loss in the high-density medium formed in heavy-ion collisions. They place important constraints for the understanding of the heavy-quark interaction with the hot and dense QCD medium.
Experimental results are presented on event-by-event net-proton fluctuation measurements in Pb–Pb collisions at √sNN = 2.76 TeV, recorded by the ALICE detector at the CERN LHC. These measurements have as their ultimate goal an experimental test of Lattice QCD (LQCD) predictions on second and higher order cumulants of net-baryon distributions to search for critical behavior near the QCD phase boundary. Before confronting them with LQCD predictions, account has to be taken of correlations stemming from baryon number conservation as well as fluctuations of participating nucleons. Both effects influence the experimental measurements and are usually not considered in theoretical calculations. For the first time, it is shown that event-by-event baryon number conservation leads to subtle long-range correlations arising from very early interactions in the collisions.
Systematic studies of charge-dependent two- and three-particle correlations in Pb-Pb collisions at sNN−−−√ = 2.76 and 5.02 TeV used to probe the Chiral Magnetic Effect (CME) are presented. These measurements are performed for charged particles in the pseudorapidity (η) and transverse momentum (pT) ranges |η| < 0.8 and 0.2 < pT < 5 GeV/c. A significant charge-dependent signal that becomes more pronounced for peripheral collisions is reported for the CME-sensitive correlators γ1, 1 = 〈cos(φα + φβ − 2Ψ2)〉 and γ1, − 3 = 〈cos(φα − 3φβ + 2Ψ2)〉. The results are used to estimate the contribution of background effects, associated with local charge conservation coupled to anisotropic flow modulations, to measurements of the CME. A blast-wave parametrisation that incorporates local charge conservation tuned to reproduce the centrality dependent background effects is not able to fully describe the measured γ1,1. Finally, the charge and centrality dependence of mixed-harmonics three-particle correlations, of the form γ1, 2 = 〈cos(φα + 2φβ − 3Ψ3)〉, which are insensitive to the CME signal, verify again that background contributions dominate the measurement of γ1,1.
Neutral pion (π0) and η meson production cross sections were measured up to unprecedentedly high transverse momenta (pT) in p–Pb collisions at √sNN = 8.16 TeV. The mesons were reconstructed via their two-photon decay channel in the rapidity interval −1.3 < y < 0.3 in the ranges of 0.4 < pT < 200 GeV/c and 1.0 < pT < 50 GeV/c, respectively. The respective nuclear modification factor (RpPb) is presented for pT up to of 200 and 30 GeV/c, where the former was achieved by extending the π0 measurement in pp collisions at √s = 8 TeV using the merged cluster technique. The values of RpPb are below unity for pT < 10 GeV/c, while they are consistent with unity for pT > 10 GeV/c, leaving essentially no room for final state energy loss. The new data provide strong constraints for nuclear parton distribution and fragmentation functions over a broad kinematic range and are compared to model predictions as well as previous results at √sNN = 5.02 TeV.